- Lobbying
- Lobbying by International Myeloma Foundation
Lobbying Relationship
Bills mentioned
S.3220: Prosthetics and Custom Orthotics Parity Act of 2010
Sponsor: Olympia J. Snowe (R-Maine)
H.R.1: American Recovery and Reinvestment Act of 2009
Sponsor: David R. Obey (D-Wis.)
H.R.716: Access to Cancer Clinical Trials Act of 2009
Sponsor: Steve Israel (D-N.Y.)
S.488: Access to Cancer Clinical Trials Act of 2009
Sponsor: Sherrod Brown (D-Ohio)
S.717: 21st Century Cancer ALERT (Access to Life-Saving Early detection,...
Sponsor: Edward M. Kennedy (D-Mass.)
S.3230: NEPA Certainty Act
Sponsor: James M. Inhofe (R-Okla.)
S.3230: Departments of Labor, Health and Human Services, and Education, and...
Sponsor: Tom Harkin (D-Iowa)
H.R.2638: Consolidated Security, Disaster Assistance, and Continuing...
Sponsor: David E. Price (D-N.C.)
H.R.2642: Supplemental Appropriations Act, 2008
Sponsor: Chet Edwards (D-Texas)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Christine Murphy | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate